Minimally Invasive Surgery in Mild-to-Moderate Glaucoma Patients in Italy: Is It Time to Change?

par Costagliola C, Sbordone M, Gandolfi S, Cesari L, Furneri G, Fea AM
Publié 2020

XEN® Gel Stent: A Comprehensive Review on Its Use as a Treatment Option for Refractory Glaucoma

par Fea AM, Durr GM, Marolo P, Malinverni L, Economou MA, Ahmed I
Publié 2020

Treatment of refractory uveitic macular edema: results of a first and second implant of long-acting intravitreal dexamethasone

par Zola M, Briamonte C, Lorenzi U, Machetta F, Grignolo FM, Fea AM
Publié 2017

Recent developments in the management of dry age-related macular degeneration

par Buschini E, Fea AM, Lavia CA, Nassisi M, Pignata G, Zola M, Grignolo FM
Publié 2015

Long-term titrated IOP control with one, two, or three trabecular micro-bypass stents in open-angle glaucoma subjects on topical hypotensive medication: 42-month outcomes

par Katz LJ, Erb C, Carceller Guillamet A, Fea AM, Voskanyan L, Giamporcaro JE, Hornbeak DM
Publié 2018

Prospective, randomized study of one, two, or three trabecular bypass stents in open-angle glaucoma subjects on topical hypotensive medication

par Katz LJ, Erb C, Carceller Guillamet A, Fea AM, Voskanyan L, Wells JM, Giamporcaro JE
Publié 2015

Prospective unmasked randomized evaluation of the iStent inject® versus two ocular hypotensive agents in patients with primary open-angle glaucoma

par Fea AM, Belda JI, Rękas M, Jünemann A, Chang L, Pablo L, Voskanyan L, Katz LJ
Publié 2014